Case report: Ketogenic diet beneficial in infant with mitochondrial disease
A preterm infant diagnosed with MTDPS13, a mitochondrial disease similar to TK2d, was found to tolerate a ketogenic diet well.
A preterm infant diagnosed with MTDPS13, a mitochondrial disease similar to TK2d, was found to tolerate a ketogenic diet well.
Patients with mitochondrial DNA depletion disorders such as TK2d had significantly shorter telomeres, especially in granulocytes.
A small boost in a missing mitochondrial gene markedly improved heart function in a severe genetic disease related to TK2d.
In patients with primary mitochondrial diseases such as TK2d, mitochondrial DNA may be responsible for activating immune responses.
Twinkle, a protein essential for mitochondrial DNA copying, also works with RNA, revealing new ways it may influence TK2d.
A recent study describes four young patients with mitochondrial DNA maintenance defects who did not receive diagnoses until young adulthood.
The European Medicines Agency (EMA) has recommended approving Kygevvi (doxecitine and doxribtimine) for use in the European Union.
Twinkle-related disorders and thymidine kinase 2 deficiency (TK2d) affect the same mitochondrial DNA pathway.
Late-onset thymidine kinase 2 deficiency (TK2d) worsens over time, especially muscle strength and breathing.
The MGME1 variant affects the same mitochondrial DNA pathway as thymidine kinase 2 deficiency, possibly acting within the same spectrum.